Skip to main content
British Medical Journal logoLink to British Medical Journal
. 1979 Dec 8;2(6203):1466–1468. doi: 10.1136/bmj.2.6203.1466

Effects of indomethacin on postural hypotension in Parkinsonism.

G Abate, R M Polimeni, F Cuccurullo, P Puddu, S Lenzi
PMCID: PMC1597182  PMID: 393356

Abstract

A study was conducted to evaluate the effect of indomethacin on orthostatic hypotension in Parkinsonism. Twelve elderly patients participated and the drug was given in two-ways--as an intravenous infusion of 50 mg over 30 minutes and by mouth 50 mg thrice daily for six days. Results were assessed by measuring the degree of hypotension on standing, response to the cold pressor test, and forearm blood flow (by strain-gauge plethysmography). Indomethacin significantly reduced the fall in blood pressure on standing (P less than 0:001) and lessened or reversed orthostatic symptoms. Furthermore, there was an enhanced response to the cold pressor test and a reduction in forearm blood flow. These findings suggest that indomethacin has a positive effect on systemic vascular resistance.

Full text

PDF
1466

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bannister R., Oppenheimer D. R. Degenerative diseases of the nervous system associated with autonomic failure. Brain. 1972;95(3):457–474. doi: 10.1093/brain/95.3.457. [DOI] [PubMed] [Google Scholar]
  2. Barritt D. W., Marshall A. J. Beta blockade in essential hypertension: an analysis of response to oxprenolol. Br Heart J. 1977 Aug;39(8):825–828. doi: 10.1136/hrt.39.8.825. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Ibrahim M. M., Tarazi R. C., Dustan H. P. Orthostatic hypotension: mechanisms and management. Am Heart J. 1975 Oct;90(4):513–520. doi: 10.1016/0002-8703(75)90435-4. [DOI] [PubMed] [Google Scholar]
  4. Indomethacin for Shy-Drager syndrome. Lancet. 1978 Jun 17;1(8077):1312–1313. [PubMed] [Google Scholar]
  5. Kochar M. S., Itskovitz H. D. Treatment of idiopathic orthostatic hypotension (Shy-Drager syndrome) with indomethacin. Lancet. 1978 May 13;1(8072):1011–1014. doi: 10.1016/s0140-6736(78)90737-7. [DOI] [PubMed] [Google Scholar]
  6. Norby L., Mark A. L., Kaloyanides G. J. On the pathogenesis of Bartter's syndrome: report of studies in a patient with this disorder. Clin Nephrol. 1976 Sep;6(3):404–413. [PubMed] [Google Scholar]
  7. Rajput A. H., Rozdilsky B. Dysautonomia in Parkinsonism: a clinicopathological study. J Neurol Neurosurg Psychiatry. 1976 Nov;39(11):1092–1100. doi: 10.1136/jnnp.39.11.1092. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Richards C. J., Mark A. L., Van Orden D. E., Kaloyanides G. J. Effects of indomethacin on the vascular abnormalities of Bartter's syndrome. Circulation. 1978 Sep;58(3 Pt 1):544–549. doi: 10.1161/01.cir.58.3.544. [DOI] [PubMed] [Google Scholar]
  9. SHY G. M., DRAGER G. A. A neurological syndrome associated with orthostatic hypotension: a clinical-pathologic study. Arch Neurol. 1960 May;2:511–527. doi: 10.1001/archneur.1960.03840110025004. [DOI] [PubMed] [Google Scholar]
  10. Wennmalm A. Influence of indomethacin on the systemic and pulmonary vascular resistance in man. Clin Sci Mol Med. 1978 Feb;54(2):141–145. doi: 10.1042/cs0540141. [DOI] [PubMed] [Google Scholar]

Articles from British Medical Journal are provided here courtesy of BMJ Publishing Group

RESOURCES